Beruflich Dokumente
Kultur Dokumente
coli O113:H10)
Control Standard Endotoxin (CSE)
Materials:
1) Control Standard Endotoxin (CSE), 0.5 µg/vial, (catalog #E0005).
2) LAL Reagent Water (LRW). Use sterile water for injection or
irrigation (no bacteriostat) or another water certified as an LRW
(see lysate package insert).
3) 5 mL sterile disposable pipet.
4) Parafilm “M”® (American National Can).
5) Dilution tubes (glass tubes depyrogenated by dry heat or sterile,
polystyrene disposables).*
Procedure:
1) Remove the metal seal from the vial and aseptically remove the
stopper.
2) Add LRW to the vial. Recommended reconstitution volume is
5 mL, however, alternate volumes may be used to achieve
desired concentration of stock solution.
a. To reconstitute with a pipet, break the vacuum by lifting the
stopper just enough to allow air to enter, remove the stopper
and add LRW. Seal the vial with Parafilm.
3) Vortex vigorously for one minute, at 5-10 minute intervals over
a 30-60 minute period at room temperature.
4) Store reconstituted CSE at 2-8oC for not more than four weeks.
Do not freeze CSE.
5) Vortex the CSE for at least 30 seconds immediately before
making the first dilution and then make appropriate dilutions
to achieve desired concentrations. The dilutions may be initiated
with three serial tenfold dilutions of the stock concentration
(100 ng/mL when reconstituted with 5 mL). Serial two-fold dilu-
tions may then be made to bracket the sensitivity of the LAL or
make dilutions appropriate for the turbidimetric or chromogenic
method. Vortex between dilutions.
Potency
The potency of a given lot of CSE is determined with a specific lot
of LAL reagent relative to the current FDA or USP lot of reference
standard endotoxin (RSE). The potency (EU/ng) is used to convert
units of reconstituted CSE from ng/ml to EU/ml. Certificates of
analysis stating potency are available from Associates of Cape Cod,
Inc. They can be obtained from Customer Service or our website at
www.acciusa.com. You must provide the lot number of both the
CSE and LAL reagent when making a request.
Method A
1) Remove the label, metal seal and stopper from each vial and
cover the vials with a double layer of aluminum foil.
2) Retain a minimum of two vials for use as positive controls.
3) Place the challenge vials in the oven load to be used for the
validation.
4) At the end of the depyrogenation process, collect the vials for
testing.
5) Reconstitute processed and control vials of CSE according to the
procedure on the reverse side of this sheet.
6) Test all vials as unknowns according to the package insert
included with the lysate.
7) Calculate the reduction in endotoxin between the control vials
and the processed vials (mean measured concentration in con-
trol vials divided by the mean measured concentration in process
vials). If the value is 1000 or greater, then the oven has
achieved a 3-log or greater reduction.**
Method B
1) Reconstitute a vial according to the procedure on the reverse
side of this sheet.
2) Add small aliquots or dilutions of the CSE to material to be
depyrogenated. Add an amount sufficient to determine at least
three log removal. Take into account any dilution involved to
recover added endotoxin and any loss due to non-recoverable
adsorption to the vessel. Include at least two vessels as “recov-
ery” controls.
3) Run material through the depyrogenation procedure.
4) Recover CSE from materials using a minimum amount of LAL
reagent water (LRW).
5) Test with LAL as above.
6) Calculate the reduction in endotoxin as indicated in step 7
above.
Bibliography
1. Tsuji, K., and A.R. Lewis. 1978. Dry-heat destruction of lipopolysaccharide:
Mathematical approach to process validation. Appl. Environ. Microbiol. 36:715-719.
2. Tsuji, K., and S.J. Harrison. 1978. Dry-heat destruction of lipopolysaccharide: dry-
heat destruction kinetics. Appl. Environ. Microbiol. 36:710-714.
3. Validation of dry heat processes used for sterilization and depyrogenation, Tech. Rpt.
No. 3, Parenteral Drug Association, Inc. (1981).
4. Akers, M.J., K.M. Ketron, and B.R. Thompson. 1982. F value requirements for the
destruction of endotoxin in the validation of dry heat sterilization/depyrogenation
cycles. J. Parenter. Sci. Technol. 36:23-27.
5. Depyrogenation, Tech. Rpt. No. 7, Parenteral Drug Association, Inc. (1985).
6. LAL UPDATE®, Vol. 4, No. 1, 1986.
7. Novitsky, T.J., J. Schmidt-Gengenbach, and J.F. Remillard. 1986. Factors affecting the
recovery of endotoxin adsorbed to container surfaces. J. Parenter. Sci. Technol.
40:284-286.
8. Avis, K.E., R.C. Jewell, and J.D. Ludwig. 1987. Studies on the thermal destruction of
Escherichia coli endotoxin. J. Parenter. Sci. Technol. 41:49-56.
9. LAL UPDATE®, Vol. 6, No. 2, 1988.
10. Ludwig, J.D., and K.E. Avis. 1988. Validation of a heating cell for precisely controlled
studies on the thermal destruction of endotoxin in glass. J. Parenter. Sci. Technol.
43:9-14.
11. Baird, R. 1988. Validation of dry heat tunnels and ovens. Pharm. Engineer. 8:31-33.
12. Ludwig, J.D., and K.E. Avis. 1989. Recovery of endotoxin preparations from the
surface of glass capillary tubes. J. Parenter. Sci. Technol. 43:276-278.
13. LAL UPDATE®, Vol. 8, No. 1, 1990.
14. Ludwig, J.D., and K.E. Avis. 1990. Dry heat inactivation of endotoxin on the surface
of glass. J. Parenter. Sci. Technol. 44:412.
15. LAL UPDATE®, Vol. 11, No. 5, 1993.
Endotoxin
(E. coli O113:H10)